Multiple Oral Doses Of PH-797804 In Healthy Japanese Adult Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

October 31, 2010

Primary Completion Date

February 28, 2011

Study Completion Date

February 28, 2011

Conditions
Healthy
Interventions
DRUG

1 mg

1 mg or placebo a material sparing tablet per day for 10 days

DRUG

5 mg

5 mg or placebo as material sparing tablet per day for 10 days

DRUG

10 mg

10 mg or placebo as a material sparing tablet per day for 10 days

Trial Locations (2)

90232

Pfizer Investigational Site, Culver City

91206

Pfizer Investigational Site, Glendale

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Pfizer

INDUSTRY